FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.046
EU - Europa 7.377
AS - Asia 5.495
SA - Sud America 860
AF - Africa 149
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.948
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.836
GB - Regno Unito 2.031
IT - Italia 1.892
SG - Singapore 1.693
CN - Cina 1.539
DE - Germania 890
VN - Vietnam 770
BR - Brasile 685
SE - Svezia 627
HK - Hong Kong 502
FR - Francia 438
RU - Federazione Russa 293
FI - Finlandia 263
UA - Ucraina 260
PL - Polonia 198
TR - Turchia 187
IN - India 159
KR - Corea 159
CA - Canada 107
BG - Bulgaria 93
NL - Olanda 74
JP - Giappone 64
BD - Bangladesh 62
ID - Indonesia 62
MX - Messico 62
IQ - Iraq 60
AR - Argentina 59
ZA - Sudafrica 50
BE - Belgio 45
IE - Irlanda 41
ES - Italia 40
AE - Emirati Arabi Uniti 35
CH - Svizzera 34
LT - Lituania 31
PK - Pakistan 31
AT - Austria 29
SA - Arabia Saudita 23
CL - Cile 22
EC - Ecuador 21
UZ - Uzbekistan 21
MA - Marocco 19
CO - Colombia 18
MY - Malesia 18
PH - Filippine 16
VE - Venezuela 16
PY - Paraguay 15
CZ - Repubblica Ceca 14
DZ - Algeria 14
EG - Egitto 14
PT - Portogallo 14
AZ - Azerbaigian 12
JO - Giordania 12
DK - Danimarca 11
ET - Etiopia 11
IR - Iran 11
KE - Kenya 11
HU - Ungheria 10
PE - Perù 10
TN - Tunisia 10
BO - Bolivia 8
BY - Bielorussia 8
AU - Australia 7
BH - Bahrain 7
EU - Europa 7
AL - Albania 6
DO - Repubblica Dominicana 6
RO - Romania 6
SN - Senegal 6
UY - Uruguay 6
JM - Giamaica 5
KZ - Kazakistan 5
TW - Taiwan 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
TZ - Tanzania 4
GD - Grenada 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
Totale 26.918
Salva come PNG Salva come JPEG
Città #
Southend 1.466
Fairfield 1.294
Ashburn 1.274
Santa Clara 1.089
Singapore 1.044
Woodbridge 889
Chandler 753
Houston 600
Seattle 525
Ann Arbor 512
Hong Kong 490
Jacksonville 467
Dearborn 458
Cambridge 456
San Jose 456
Wilmington 444
Hefei 392
Frankfurt am Main 388
Nyköping 363
Beijing 283
Modena 273
London 240
Ho Chi Minh City 224
Hanoi 185
New York 174
Los Angeles 171
Helsinki 161
Council Bluffs 146
Kraków 145
Seoul 144
The Dalles 121
Chicago 108
Princeton 98
Sofia 92
Izmir 91
Milan 90
San Diego 90
Munich 89
Eugene 87
Moscow 84
Shanghai 84
Lauterbourg 82
Fremont 76
Orem 74
São Paulo 68
Redwood City 67
Boardman 57
Rome 56
Bologna 54
Porto Alegre 53
Buffalo 49
Tokyo 47
Bremen 46
Da Nang 42
Warsaw 42
Salt Lake City 41
Brussels 40
Dublin 40
Des Moines 35
Brooklyn 32
Guangzhou 32
Chennai 31
Jakarta 31
Grafing 30
Naples 30
Verona 30
Dallas 29
Atlanta 28
Denver 28
Falls Church 28
Ottawa 27
Stockholm 27
Haiphong 26
Phoenix 26
Turku 26
Baghdad 25
Belo Horizonte 23
Cape Town 23
Columbus 23
Montreal 23
Parma 23
Amsterdam 22
Norwalk 22
Elk Grove Village 21
Toronto 20
Marseille 19
Mumbai 19
Poplar 19
Tampa 19
Paris 18
Manchester 17
Mexico City 17
Biên Hòa 16
Dhaka 16
Dong Ket 16
Milwaukee 16
Reggio Emilia 16
San Francisco 16
Tashkent 16
Brasília 15
Totale 18.450
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 815
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 480
Metodo per la funzionalizzazione sito specifica di molecole proteiche 424
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 422
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 420
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 420
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 414
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 406
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 403
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 398
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 395
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 395
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 393
Biochemistry: Anchors away 382
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 381
Antibacterial agent discovery using thymidylate synthase biolibrary screening 375
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 371
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 362
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 358
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 358
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 355
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 354
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 348
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 342
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 341
A proteomic approach to investigate the mechanism of action of anticancer peptides 339
Allosteric Inhibition of human Thymidylate Synthase. 339
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 337
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 336
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 336
Crystal Structure of histidine-tagged human thymidylate synthase 334
Current and Future Chemotherapy for Chagas Disease 331
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 321
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 319
ANTICANCER DRUGS 318
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 316
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 314
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 312
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 310
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 310
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 310
Biochemical effects of riluzole on Leishmania parasites 309
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 308
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 308
Thymidylate synthase structure, function and implication in drug discovery 305
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 305
Homodimeric Enzymes as Drug Targets 298
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 290
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 290
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 290
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 290
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 289
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 287
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 287
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 283
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 280
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 279
Update on antifolate drugs targets 277
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 274
Target-based approaches for the discovery of new antimycobacterial drugs 272
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 270
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 264
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 260
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 257
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 246
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 246
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 244
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 244
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 230
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 229
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 227
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 221
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 217
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 216
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 215
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 215
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 207
Compounds having antiparasitic activity 204
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 196
Ovarian Cancer Drug Resistance 195
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 192
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 189
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 182
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 177
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 173
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 169
Medicinal chemistry in parasitology 164
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 161
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 149
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 134
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 129
Totale 27.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021893 0 0 0 0 0 0 0 0 0 530 240 123
2021/20222.086 92 189 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20266.993 456 309 563 906 1.222 557 1.036 388 834 722 0 0
Totale 27.237